Shots:
Mahesh talked about the data presented on its lead candidate in hepatocellular carcinoma at the AACR 2022
Mahesh also spoke about Omega’s drug-development platform that identifies and targets specific and unique DNA sequences of regulatory elements
The interview gives a profound grip on Omega’s development strategies to use mRNA therapeutics as a new class…
Shots
Mai-Britt talked about the P-I/II clinical trial data and study design of its lead candidate in metastatic melanoma in an e-poster presentation at AACR 2022
She also spoke about IO Biotech’s unique platform with tumor defense mechanisms to kill cancer cells
The interview gives a profound understanding of how IO Biotech is advancing to…
Shots:
Richard spoke about the results from the Phase 1 AURELIO-03 study of IL-15 superagonist
Richard also emphasized the clinical benefits of the IL-15 superagonist when combined with pembrolizumab
The interview gives a profound understanding of the existing & developing cancer therapies as treatment options for solid tumors
Smriti: Explain the details (MOA, ROA, formulations, etc.)…

